Recent investigations prove the inhibitory effect of Maspin, a serine protease inhibitor, on motility and invasiveness of prostate cancer cells in vitro. In addition, this year a p53-dependent pathway of Maspin regulation was detected on prostate cancer cell lines. It was the aim of our study to investigate the correlation between Maspin and p53 expression on specimens of radical prostatectomies and their in¯uence on the recurrence-free and overall survival of the patients.
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Method
The tumours of 84 patients who underwent radical prostatectomies because of localised prostate cancers would be examined immunohistochemically in regard to their Maspin and p53 expression. The results were correlated with the clinical follow-up.
Results
During a median follow-up of 68 months (9 ± 197 months), 23 of 40 patients (57.5%) with a negative Maspin expression in comparison to 8 of 44 patients (18.2%) with a retained staining developed a tumour recurrence (P`0.02, Spearman). The increased expression of mutated p53 was signi®cantly correlated with a decreased Maspin reaction (P`0.03, Spearman). Additionally a reduced Maspin expression was signi®cantly correlated with a high Gleason grade (P`0.03, Spearman) and an advanced pT-stage (P`0.002, Spearman).
Conclusion
For the ®rst time, the presented data describe a possible relevance of the proteinase inhibitor Maspin for the tumour progression of patients with localised prostate after radical prostatectomy. Our results support the supposed p53-dependent regulation mechanism for the Maspin expression in malignant prostate tumours.
